Source: VIRTRIAL Blog

VIRTRIAL Blog The Case for Cognitive Assessments in Phase I Clinical Trials

Patient-focused drug development is increasingly important to regulators. The drug development process now emphasizes patient-reported outcomes, which are an essential... The post The Case for Cognitive Assessments in Phase I Clinical Trials appeared first on Signant Health.

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Mark S. Hanley's photo - President & CEO of VirTrial

President & CEO

Mark S. Hanley

CEO Approval Rating

90/100

Read more